Tags: Drug.

Saroglitazar (INN trade name Lipaglyn) is a drug for the treatment of type II diabetes. It is approved for use in India by the Drug Controller General of India.

Saroglitazar_skeletal.svg
ATC prefix
None
CAS number
495399-09-2
IUPAC name
(2S)-2-Ethoxy-3-[4-(2-2-methyl-5-[4-(methylsulfanyl)phenyl]-1H-pyrrol-1-ylethoxy)phenyl]propanoic acid
PubChem
60151560

Loading...

This page contains content from the copyrighted Wikipedia article "Saroglitazar"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.